Bicycle Therapeutics PLC SEC filings BCYC

Bicycle Therapeutics PLC has 660 filings in SEC EDGAR's recent list, going back to Dec 21, 2018. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

Bicycle Therapeutics PLC SEC filings
Form Description Filed Period
4/A Filing Oct 7, 2026 Oct 2, 2026
4 Insider transaction Oct 6, 2026 Oct 2, 2026
4 Insider transaction Oct 6, 2026 Oct 2, 2026
4 Insider transaction Oct 6, 2026 Oct 2, 2026
4 Insider transaction Oct 6, 2026 Oct 2, 2026
4 Insider transaction Oct 6, 2026 Oct 2, 2026
4 Insider transaction Oct 6, 2026 Oct 2, 2026
3/A Filing Oct 6, 2026 Jun 22, 2023
144 Notice of proposed sale Oct 2, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
144 Notice of proposed sale Jul 2, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 4, 2026 —
4 Insider transaction Apr 6, 2026 Apr 2, 2026
4 Insider transaction Apr 6, 2026 Apr 2, 2026
4 Insider transaction Apr 6, 2026 Apr 2, 2026
4 Insider transaction Apr 6, 2026 Apr 2, 2026
4 Insider transaction Apr 6, 2026 Apr 2, 2026
144 Notice of proposed sale Apr 2, 2026 —
144 Notice of proposed sale Apr 2, 2026 —
144 Notice of proposed sale Apr 2, 2026 —
144 Notice of proposed sale Apr 2, 2026 —
144 Notice of proposed sale Apr 2, 2026 —
144 Notice of proposed sale Apr 2, 2026 —
144 Notice of proposed sale Apr 2, 2026 —
3 Initial insider ownership Mar 25, 2026 Mar 17, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 4, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Mar 3, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 3, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 3, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 18, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 11, 2026 —
4 Insider transaction Feb 4, 2026 Feb 3, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
144 Notice of proposed sale Jan 5, 2026 —
144 Notice of proposed sale Jan 2, 2026 —
144 Notice of proposed sale Jan 2, 2026 —
144 Notice of proposed sale Jan 2, 2026 —
144 Notice of proposed sale Jan 2, 2026 —
144 Notice of proposed sale Jan 2, 2026 —
144 Notice of proposed sale Jan 2, 2026 —
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
144 Notice of proposed sale Oct 2, 2025 —
144 Notice of proposed sale Oct 2, 2025 —
144 Notice of proposed sale Oct 2, 2025 —
144 Notice of proposed sale Oct 2, 2025 —
144 Notice of proposed sale Oct 2, 2025 —
144 Notice of proposed sale Oct 2, 2025 —
4 Insider transaction Sep 10, 2025 Sep 8, 2025
4 Insider transaction Sep 10, 2025 Sep 8, 2025
3 Initial insider ownership Sep 10, 2025 Sep 8, 2025
3 Initial insider ownership Sep 10, 2025 Sep 8, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
4 Insider transaction Aug 14, 2025 Aug 12, 2025
3 Initial insider ownership Aug 14, 2025 Aug 12, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
4 Insider transaction Jul 7, 2025 Jul 2, 2025
4 Insider transaction Jul 7, 2025 Jul 2, 2025
4 Insider transaction Jul 7, 2025 Jul 2, 2025
4 Insider transaction Jul 7, 2025 Jul 2, 2025
4 Insider transaction Jul 7, 2025 Jul 2, 2025
4 Insider transaction Jul 7, 2025 Jul 2, 2025
144 Notice of proposed sale Jul 2, 2025 —
144 Notice of proposed sale Jul 2, 2025 —
144 Notice of proposed sale Jul 2, 2025 —
144 Notice of proposed sale Jul 2, 2025 —
144 Notice of proposed sale Jul 2, 2025 —
144 Notice of proposed sale Jul 2, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
4 Insider transaction Apr 4, 2025 Apr 2, 2025
4 Insider transaction Apr 4, 2025 Apr 2, 2025
4 Insider transaction Apr 4, 2025 Apr 2, 2025
4 Insider transaction Apr 4, 2025 Apr 2, 2025
4 Insider transaction Apr 4, 2025 Apr 2, 2025
4 Insider transaction Apr 4, 2025 Apr 2, 2025
144 Notice of proposed sale Apr 2, 2025 —
144 Notice of proposed sale Apr 2, 2025 —
144 Notice of proposed sale Apr 2, 2025 —
144 Notice of proposed sale Apr 2, 2025 —
144 Notice of proposed sale Apr 2, 2025 —
144 Notice of proposed sale Apr 2, 2025 —
144 Notice of proposed sale Apr 2, 2025 —
144 Notice of proposed sale Apr 2, 2025 —
4 Insider transaction Mar 27, 2025 Mar 25, 2025
3 Initial insider ownership Mar 27, 2025 Mar 25, 2025
4 Insider transaction Mar 27, 2025 Mar 25, 2025
3 Initial insider ownership Mar 27, 2025 Mar 25, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 11, 2025 —
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
144 Notice of proposed sale Jan 6, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Dec 20, 2024 —
SCHEDULE 13G Ownership over 5% (passive) Dec 19, 2024 —
SC 13D/A Amended ownership over 5% (active) Dec 17, 2024 —
4 Insider transaction Dec 17, 2024 Dec 13, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 13, 2024 —
4 Insider transaction Nov 13, 2024 Nov 11, 2024
144 Notice of proposed sale Nov 12, 2024 —
4 Insider transaction Oct 4, 2024 Oct 3, 2024
4 Insider transaction Oct 4, 2024 Oct 3, 2024
4 Insider transaction Oct 4, 2024 Oct 3, 2024
4 Insider transaction Oct 4, 2024 Oct 3, 2024
4 Insider transaction Oct 4, 2024 Oct 3, 2024
4 Insider transaction Oct 4, 2024 Oct 3, 2024
144 Notice of proposed sale Oct 3, 2024 —
144 Notice of proposed sale Oct 3, 2024 —
144 Notice of proposed sale Oct 3, 2024 —
144 Notice of proposed sale Oct 3, 2024 —
144 Notice of proposed sale Oct 3, 2024 —
144 Notice of proposed sale Oct 3, 2024 —
144 Notice of proposed sale Oct 3, 2024 —
4 Insider transaction Jul 8, 2024 Jul 3, 2024
4 Insider transaction Jul 8, 2024 Jul 3, 2024
4 Insider transaction Jul 8, 2024 Jul 3, 2024
4 Insider transaction Jul 8, 2024 Jul 3, 2024
4 Insider transaction Jul 8, 2024 Jul 3, 2024
4 Insider transaction Jul 8, 2024 Jul 3, 2024
4 Insider transaction Jul 8, 2024 Jul 3, 2024
144 Notice of proposed sale Jul 3, 2024 —
144 Notice of proposed sale Jul 3, 2024 —
144 Notice of proposed sale Jul 3, 2024 —
144 Notice of proposed sale Jul 3, 2024 —
144 Notice of proposed sale Jul 3, 2024 —
144 Notice of proposed sale Jul 3, 2024 —
144 Notice of proposed sale Jul 3, 2024 —
4 Insider transaction Jun 20, 2024 Jun 17, 2024
SC 13G Ownership over 5% (passive) Jun 7, 2024 —
4 Insider transaction May 29, 2024 May 29, 2024
SC 13D/A Amended ownership over 5% (active) May 28, 2024 —
4 Insider transaction Apr 22, 2024 Apr 18, 2024
SC 13D Ownership over 5% (active) Apr 18, 2024 —
3 Initial insider ownership Apr 18, 2024 Apr 18, 2024
4 Insider transaction Apr 12, 2024 Apr 11, 2024
144 Notice of proposed sale Apr 11, 2024 —
4 Insider transaction Apr 5, 2024 Apr 3, 2024
4 Insider transaction Apr 5, 2024 Apr 3, 2024
4 Insider transaction Apr 5, 2024 Apr 3, 2024
4 Insider transaction Apr 5, 2024 Apr 3, 2024
4 Insider transaction Apr 5, 2024 Apr 3, 2024
4 Insider transaction Apr 5, 2024 Apr 3, 2024
144 Notice of proposed sale Apr 3, 2024 —
144 Notice of proposed sale Apr 3, 2024 —
144 Notice of proposed sale Apr 3, 2024 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BCYC (Nasdaq)
Fiscal year ends
December 31
Incorporated in
United Kingdom
Headquarters
Cambridge, United Kingdom
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1761612
Former names
BICYCLE THERAPEUTICS Ltd (until May 24, 2019)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.